Okabayashi Tamaki, Sasaki Tadahiro, Masrinoul Promsin, Chantawat Nantarat, Yoksan Sutee, Nitatpattana Narong, Chusri Sarunyou, Morales Vargas Ronald E, Grandadam Marc, Brey Paul T, Soegijanto Soegeng, Mulyantno Kris Cahyo, Churrotin Siti, Kotaki Tomohiro, Faye Oumar, Faye Ousmane, Sow Abdourahmane, Sall Amadou Alpha, Puiprom Orapim, Chaichana Panjaporn, Kurosu Takeshi, Kato Seiji, Kosaka Mieko, Ramasoota Pongrama, Ikuta Kazuyoshi
Mahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
J Clin Microbiol. 2015 Feb;53(2):382-8. doi: 10.1128/JCM.02033-14. Epub 2014 Nov 19.
Chikungunya fever is a mosquito-borne disease of key public health importance in tropical and subtropical countries. Although severe joint pain is the most distinguishing feature of chikungunya fever, diagnosis remains difficult because the symptoms of chikungunya fever are shared by many pathogens, including dengue fever. The present study aimed to develop a new immunochromatographic diagnosis test for the detection of chikungunya virus antigen in serum. Mice were immunized with isolates from patients with Thai chikungunya fever, East/Central/South African genotype, to produce mouse monoclonal antibodies against chikungunya virus. Using these monoclonal antibodies, a new diagnostic test was developed and evaluated for the detection of chikungunya virus. The newly developed diagnostic test reacted with not only the East/Central/South African genotype but also with the Asian and West African genotypes of chikungunya virus. Testing of sera from patients suspected to have chikungunya fever in Thailand (n = 50), Laos (n = 54), Indonesia (n = 2), and Senegal (n = 6) revealed sensitivity, specificity, and real-time PCR (RT-PCR) agreement values of 89.4%, 94.4%, and 91.1%, respectively. In our study using serial samples, a new diagnostic test showed high agreement with the RT-PCR within the first 5 days after onset. A rapid diagnostic test was developed using mouse monoclonal antibodies that react with chikungunya virus envelope proteins. The diagnostic accuracy of our test is clinically acceptable for chikungunya fever in the acute phase.
基孔肯雅热是一种在热带和亚热带国家具有重要公共卫生意义的蚊媒疾病。虽然严重的关节疼痛是基孔肯雅热最显著的特征,但由于包括登革热在内的许多病原体都有与基孔肯雅热相同的症状,因此诊断仍然困难。本研究旨在开发一种新的免疫层析诊断试验,用于检测血清中的基孔肯雅病毒抗原。用泰国基孔肯雅热患者分离株(东/中/南非基因型)免疫小鼠,以产生抗基孔肯雅病毒的小鼠单克隆抗体。利用这些单克隆抗体,开发并评估了一种用于检测基孔肯雅病毒的新诊断试验。新开发的诊断试验不仅与基孔肯雅病毒的东/中/南非基因型反应,还与亚洲和西非基因型反应。对泰国(n = 50)、老挝(n = 54)、印度尼西亚(n = 2)和塞内加尔(n = 6)疑似患有基孔肯雅热的患者血清进行检测,结果显示敏感性、特异性和实时聚合酶链反应(RT-PCR)一致性值分别为89.4%、94.4%和91.1%。在我们使用系列样本的研究中,一种新的诊断试验在发病后的前5天内与RT-PCR显示出高度一致性。利用与基孔肯雅病毒包膜蛋白反应的小鼠单克隆抗体开发了一种快速诊断试验。我们试验的诊断准确性在临床上对于急性期的基孔肯雅热是可以接受的。